ActualitésAssisté par IA

Alembic Pharmaceutical Welcomes Prag Goel As Its New Vice President Of Sales And Marketing

Alembic Pharma appoints Prag Goel as VP of Sales & Marketing, bringing 30 years of expertise across diverse therapy areas and global firms.

Simantini Singh Deo
Par Simantini Singh Deo
Rédacteur principal de contenu
2 janv. 2025Updated Jun 26, 2025 · 2 min de lecture
Alembic Pharmaceutical Welcomes Prag Goel As Its New Vice President Of Sales And Marketing
https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.indianpharmapost.com%2Fpeople%2Flite%2Falembic-pharmaceuticals-appoints-prag-goel-as-vp-sales-and-marketing-megacare-enteron-and-osteofit-business-divisions-16604&psig=AOvVaw3owfqKCe8WAwkDxIgOpgeI&ust=1735901715414000&source=images&cd=vfe&opi=89978449&ved=0CBUQjRxqFwoTCODctv7v1ooDFQAAAAAdAAAAABAE
Journalisme assisté par IA
Reviewed by Simantini Singh Deo, Rédacteur principal de contenu

Alembic Pharmaceuticals Limited has announced the appointment of Prag Goel as Vice President of the company starting from January 1st, 2025. Mr. Goel will oversee sales and marketing. Mr. Prag Goel has pursued his B.Sc. from Kurukshetra University. Mr. Goel is a seasoned professional in the pharmaceutical company with almost 30 years of comprehensive experience in the industry. 

His work experience in various therapy areas includes Pediatrics, Cardiovascular, Diabetic, anti-infective, Gastrointestinal, gynecology rheumatology Anti-TB dermatology, Anti-infective, and critical care therapy areas in India as well as multi-national organizations. He has specialized in creating high-performance sales teams and achieving organizational goals on an ongoing basis. He was involved with firms like Lupin Limited, Glenmark India Limited, Pfizer India Limited, AstraZeneca Pharma India Ltd, and various other prestigious organizations.


Simantini Singh Deo
Written by
Simantini Singh Deo
Rédacteur principal de contenu

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.

Discussion

Chargement de la discussion…

Plus dans Pharma News

Tous les articles →